clinical trial · NCT06109649
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
Clinuvel, Inc.·phase3·active not recruiting·n = 200
VitiligoAfamelanotide and NB-UVB LightNB-UVB Light
brief summary
The CUV105 study will assess the efficacy and safety of afamelanotide and NB-UVB light in patients with vitiligo on the body and face versus NB-UVB light alone.
started
Oct 11, 2023
primary completion
Dec 1, 2025
completion
Jun 1, 2026
last updated
Jul 8, 2025
official title
A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet B (NB-UVB) Light Versus NB-UVB Light Alone in the Treatment of Vitiligo
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol